Bromelain Benefits: Mechanisms, Evidence, and Therapeutic Potential in Human Health

Introduction

Bromelain comprises a mixture of **proteolytic enzymes** extracted from *Ananas comosus* (pineapple) stems and fruit. These enzymes are **cysteine proteases** that retain catalytic activity under physiological conditions, enabling them to interact with proteins, inflammatory mediators, and cellular receptors in diverse biological systems. Recent reviews, including a 2022 analysis in *Expert Opinion in Biological Therapy*, highlight bromelain’s mechanistic versatility and translational promise across inflammatory, immunological, and tissue repair contexts (Rajan et al., 2022).  

This article synthesizes key findings from clinical and preclinical studies to elucidate bromelain’s **biochemical actions and potential therapeutic benefits**, focusing on inflammation modulation, tissue healing, digestive support, and emerging roles in chronic disease contexts.

Biochemical Properties and Mechanisms of Action

Bromelain’s proteolytic activity allows it to hydrolyze peptide bonds within proteins. Unlike many digestive enzymes that require highly specific pH ranges, bromelain remains active in both acidic and alkaline environments, contributing to its systemic effects after ingestion (Agrawal et al., 2022; MDPI).

Anti‑Inflammatory and Immunomodulatory Actions

A central mechanism of bromelain’s therapeutic effects is modulation of inflammation. Studies demonstrate that bromelain:

• Reduces pro‑inflammatory cytokines, such as interleukin‑1β (IL‑1β), IL‑6, and tumor necrosis factor‑α (TNF‑α) in macrophages and immune cell models, counteracting excessive inflammatory signaling pathways such as NF‑κB and MAPKs.
• Downregulates COX‑2 and prostaglandin E₂ (PGE₂) expression, decreasing key mediators of pain and vascular inflammation.  
• Modulates immune cell surface markers involved in adhesion and migration, influencing leukocyte trafficking in chronic inflammatory conditions.  

These effects have been observed in both in vitro models and animal studies, providing mechanistic support for clinical applications.

Proteolysis and Tissue Remodeling

Proteolysis underlies bromelain’s ability to influence **tissue dynamics**. In vivo studies show that bromelain enhances fibrinolytic activity, degrades fibrin, and potentially assists in the clearing of necrotic tissue. This enzymatic debridement has been translated into approved topical therapies for burn wounds that reduce the need for surgical excision.

Inflammatory and Pain‑Related Conditions

Osteoarthritis and Musculoskeletal Pain

Multiple clinical studies suggest that bromelain can decrease **pain, stiffness, and swelling** in osteoarthritis and related conditions. For example, research indicates that bromelain may act as an alternative or adjunct to non‑steroidal anti‑inflammatory drugs (NSAIDs), mitigating inflammation and pain mediators such as bradykinin.

Postoperative Pain and Edema

Systematic reviews and meta‑analyses of randomized clinical trials show bromelain’s utility in **postoperative pain control**, particularly in dental surgery settings (third molar extraction and jaw surgery). Although effects on edema and trismus (jaw stiffness) are mixed, bromelain has been associated with reduced pain at 48–72 hours postoperatively.

Sinusitis and Upper‑Respiratory Inflammation

Oral bromelain has been evaluated for *sinus inflammation* and symptoms such as nasal congestion, with some small studies reporting improvement in swelling and nasal discharge duration. However, evidence quality varies and further high‑quality trials are needed.

Digestive Health and Nutrient Absorption

Bromelain’s proteolytic properties facilitate digestion of dietary proteins, potentially enhancing amino acid availability and supporting improved gastrointestinal function. Supplementation has been explored in conditions like gastritis and inflammatory bowel disease (IBD), where anti‑inflammatory action may reduce mucosal irritation and discomfort.

Anticancer Potential

Preclinical evidence suggests that bromelain may exert **antiproliferative effects** on certain cancer cell lines, including colorectal cancer cells, potentially through induction of apoptosis and oxidative stress pathways. These effects have been demonstrated in vitro and require further clinical validation.

Safety Profile and Interactions

Bromelain is generally **well tolerated** when used orally, with mild gastrointestinal symptoms and rare allergic reactions reported. Bromelain’s influence on drug absorption and metabolism suggests caution when administered with anticoagulants or certain antibiotics, though clinical relevance remains under investigation.

Topically, bromelain‑based products have regulatory approval for enzymatic debridement of burn tissue, highlighting its clinical utility beyond supplementation.

Conclusion

Bromelain represents a biologically active enzyme complex with multifaceted actions relevant to inflammation modulation, tissue healing, digestive support, and emerging disease pathways. While mechanistic and early clinical evidence is promising, further rigorous clinical research is needed to fully establish its therapeutic roles.  

References 

Agrawal, P., et al. (2022). *Bromelain: A Potent Phytomedicine* [Review]. *PMC*. 

Brien, S. (2004). *Bromelain as a Treatment for Osteoarthritis: A Review*. *PMC*. turn0search22

Delgarm, P., et al. (2025). Effects of bromelain supplementation on disease activity (preprint). *Nature*. 

Faramarzi, M. (2023). *Effectiveness of Bromelain in Postoperative Healing*. *PMC*. 

Insuan, O., et al. (2021). *Anti‑Inflammatory Effect of Pineapple Rhizome Bromelain*. *PMC*. turn0search30

Kansakar, U. (2024). *Exploring the Therapeutic Potential of Bromelain*. *MDPI Nutrients*. 

Pavan, R. (2012). *Properties and Therapeutic Application of Bromelain*. *PMC*. turn0search15

Rajan, S., et al. (2022). *Expert Opinion in Biological Therapy* review on bromelain. doi:10.1080/14712598.2022.2042250

*Note:* PMC and MDPI citations refer to peer‑reviewed sources accessed via PubMed Central and MDPI journals; details may vary based onjournalformattingconventions.